Assignee
FOGHORN THERAPEUTICS INC
US·20 granted patents·34 pending applications·73 citations·filing 2019–2025
Top patents by PatentIndex Score
54 records- 0195US11560381B1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Jan 24, 2023·12 cites·12 claims
- 0295US11497752B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2019·Granted Nov 15, 2022·7 cites·6 claims
- 0395US11414416B1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Aug 16, 2022·16 cites·15 claims
- 0494US11851445B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·9 cites·6 claims
- 0594US11767330B2Citrate salt, pharmaceutical compositions, and methods of making and using the sameFOGHORN THERAPEUTICS INC·Filed 2022·Granted Sep 26, 2023·5 cites·12 claims
- 0694US11485732B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Nov 1, 2022·8 cites·18 claims
- 0792US12383560B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Aug 12, 2025·1 cites·10 claims
- 0892US11787800B2BRD9 degraders and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·3 cites·24 claims
- 0992US11773085B2Methods and compounds for treating disordersFOGHORN THERAPEUTICS INC·Filed 2020·Granted Oct 3, 2023·10 cites·4 claims
- 1086US12139487B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Nov 12, 2024·1 cites·102 claims
- 1180US12441726B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Oct 14, 2025·1 cites·40 claims
- 1279US12486262B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·0 cites·10 claims
- 1375US2026008778A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1474US12351579B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·0 cites·18 claims
- 1572US2024166668A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1671US2025066354A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1771US2024150348A1Brd9 degraders and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1870US2023129003A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1969US2024150328A1Methods and compounds for treating disordersFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2067US2023142883A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2165US2023066136A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2264US2025241931A1Methods of treating a subject having clinically significant signs and symptoms associated with blood cell differentiationFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2364US2025325553A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2462US2024190894A1Citrate salt, pharmaceutical compositions, and methods of making and using the sameFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2562US2025304596A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2661US2025302832A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2761US2025339441A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2860US12528825B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Jan 20, 2026·0 cites·18 claims
- 2959US12552775B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Feb 17, 2026·0 cites·29 claims
- 3057US2024376121A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3156US2025085300A1Stability-enhancing compositions and methods of preparing compoundsFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3255US2023149414A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3354US12509453B2BRM/BRG1 inhibitors and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Dec 30, 2025·0 cites·19 claims
- 3454US2024374605A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3554US2024024488A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3654US2023416248A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3753US2023121497A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3853US2024325370A1Therapeutic regimens of a degrader of brd9FOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3953US2023348452A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4051US2025255857A1Methods of treating androgen receptor-independent prostate cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4151US2024189318A1Therapeutic regimens of an inhibitor of the enzymatic activity of brg1 and brmFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4251US2023150974A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4350US12590079B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Mar 31, 2026·0 cites·20 claims
- 4450US2025235432A1Methods of treating cancersFOGHORN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4550US2023079819A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4649US2022193205A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4748US12391686B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Aug 19, 2025·0 cites·22 claims
- 4848US12384776B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Aug 12, 2025·0 cites·17 claims
- 4948US2023065463A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5044US2021260171A1Methods of treating disordersFOGHORN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when FOGHORN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →